Vox market audio interview with Immupharma Chairman Tim McCarthy – 19th April 2018
23rd April 2018 - 8:02 amTim McCarthy, Chairman of Immupharma discusses the topline results of the Lupuzor Pivotal Phase III Trial.
Tim McCarthy, Chairman of Immupharma discusses the topline results of the Lupuzor Pivotal Phase III Trial.